Note:
Journal of Diabetology | Volume 3
Page 17
July 25-26, 2019 | Amsterdam, Netherlands
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
Diabetes Conference 2019
3
rd
International Conference on
DIABETES, NUTRITION,
METABOLISM & MEDICARE
GLYCEMIC ACTIVITY OF CATHINONE IN TYPE 2 DIABETES-INDUCED RATS
Abdulsamad Alsalahi, Zahurin Mohamed, Zamri Chik
and
Mohammed A Alshawsh
University of Malaya, Malaysia
T
he glycemic activity of cathinone (Bioactive alkaloid of the plant Catha edulis; Khat) in non-diabetic animals
was reported, however; it’s
in vivo
glycemic activity in diabetes-induced animals has not yet been report-
ed. Therefore, the
in vitro
inhibitory effect of cathinone against α-amylase and α-glucosidase and its
in vivo
glycemic activity in diabetes-induced rats were investigated. Totally, 15 rats were fed on high-fat diet for five
weeks followed by IP-injection with 30mg/kg streptozotocin. Diabetic rats were distributed into four groups
(n=5); diabetic control (DC), 10 mg/kg glibenclamide (DG), 1.6mg/kg cathinone. Another five rats were fed on
normal diet and designed as a non-diabetic control (NC). Four weeks after treatment, rats were sacrificed to
collect blood for biochemistry and pancreas for histopathology. The
in vitro
inhibitory activity of cathinone
was significantly less potent than that of α-acarbose against α-amylase and α-glucosidase (IC50: 92.60±3.29
and 194.21±0.89µg/ml, respectively). Cathinone significantly increased fasting blood sugar, but significantly
decreased body weight and caloric intake as compared to baseline. Cathinone significantly decreased insulin
levels as compared to the DC group. In conclusion, cathinone could not exert substantial
in vitro
inhibitory
effects against α-amylase and α-glucosidase; however, it exacerbated hyperglycemia of diabetes-induced rats”.
Abdulsamad Alsalahi et al., J Diabetol 2019, Volume 3
Abdulsamad Alsalahi is about to complete his PhD from University of Malaya, Malaysia. He is a PhD student at Department of Phar-
macology, Faculty of Medicine, University of Malaya, Malaysia. He is a Lecturer at the Faculty of Pharmacy, Sana’a University, Yemen.
He has 10 publications (ISI) that have been cited 93 times, and has been serving as a reviewer of reputed BMC Complementary and
Alternative Medicine.
ahmedsamad28@yahoo.comBIOGRAPHY